Local Stocks
Energy Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Fate Therapeutics (NQ: FATE)
31.68 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:41 AM EDT, Jun 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 25
Open 31.68
Bid (Size) 31.80 (1)
Ask (Size) 37.50 (2)
Prev. Close 31.68
Today's Range 31.68 - 31.68
52wk Range 12.59 - 37.24
Shares Outstanding 52,858,446
Dividend Yield N/A
Performance
YTD
+62.71%
+62.71%
1 Month
+11.35%
+11.35%
3 Month
+2.16%
+2.16%
6 Month
+123.41%
+123.41%
1 Year
+62.80%
+62.80%
Top News
More News
Fate Therapeutics Announces FDA Clearance of IND Application for FT538, First CRISPR-edited, iPSC-derived Cell Therapy
from GlobeNewswire News Releases
Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress
from GlobeNewswire News Releases
More News
Read More
Fate Therapeutics Announces Changes to its Board of Directors
from GlobeNewswire News Releases
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2020 Financial Results
from GlobeNewswire News Releases
Fate Therapeutics Announces Preclinical Data Presentation of Novel CAR MICA/B Cell-based Cancer Immunotherapy Program at the 2020 ASGCT Annual Meeting
from GlobeNewswire News Releases
Benzinga's Top Upgrades, Downgrades For May 13, 2020
category TPVG , SAVE , Intraday Update , and 22 more.
from Benzinga
2 Top Gene Editing Stocks to Watch in June
category Market News , FATE , VRTX , and 1 more.
from Motley Fool
Here's Why Big Buyers Are Excited About This Cancer Immunotherapy Stock
category JNJ , FATE , Market News
from Motley Fool
Analysts Forecast 13% Gains Ahead For The Holdings of PTH
category ETFs
from ETF Channel
Fate Therapeutics Inc (FATE) Q1 2020 Earnings Call Transcript
category Market News , FATE
from Motley Fool
Is Fate Therapeutics a Buy?
category JNJ , FATE , Market News
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.